MEI Pharma Inc


Oppenheimer Sees 232% Upside for MEI Pharma Inc (MEIP); Here’s Why

Oppenheimer analyst Leah R. Cann initiated coverage on shares of MEI Pharma Inc (NASDAQ:MEIP) with an Outperform rating and $6.

Stock Update (NASDAQ:MEIP): MEI Pharma Inc and Helsinn Group Report Prolongation of Survival Results from Phase 2 Clinical Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia

MEI Pharma, Inc. (NASDAQ:MEIP) and Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, announced final results from a Phase …

Company Update (NASDAQ:MEIP): MEI Pharma Inc Reports Fiscal Year 2016 Results

MEI Pharma Inc (NASDAQ:MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today reported results for its fiscal year …

Stock Update (NASDAQ:MEIP): MEI Pharma Inc and Helsinn Group Enter Strategic Agreement for the Development and Commercialization of Pracinostat

MEI Pharma Inc (NASDAQ:MEIP), an oncology company focused on the clinical development of novel therapies for cancer and Helsinn, a Swiss pharmaceutical group focused on …

Wedbush Top Analyst Remains Sidelined on MEI Pharma Inc (MEIP) Despite Receiving Breakthrough Therapy Designation; Here’s Why

MEI Pharma Inc (NASDAQ:MEIP) just received Breakthrough Therapy Designation for its key pipeline drug pracinostat, anti-tumor molecule inhibitor that combined with azacitidine treats …

Company Update (NASDAQ:MEIP): MEI Pharma Inc Announces New Clinical Data from First-in-Human Study of ME-401

MEI Pharma Inc (NASDAQ:MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced new clinical data from a …

MEI Pharma Inc (MEIP) Poised To Move Higher; Here’s Why

When investing in biotech companies, I try to find undervalued companies with low-risk upcoming catalysts. For example, several months ago when Medivation (NASDAQ:MDVN) …

Stock Update (NASDAQ:MEIP): MEI Pharma Inc Appoints Dr. Christine White as Chairman of the Board

MEI Pharma Inc (NASDAQ:MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced the appointment of Christine White, …

Stock Update (NASDAQ:MEIP): MEI Pharma Inc Announces Positive Results from Phase II Study of Pracinostat in Acute Myeloid Leukemia, Plans to Initiate Phase III Registration Study

MEI Pharma Inc (NASDAQ:MEIP), an oncology company focused on the clinical development of novel therapies for cancer, today announced positive results from a …

MEI Pharma Inc (MEIP): ASH Abstract Data Supports Advancement Of Pracinostat In MDS And AML

I wrote an article last week detailing why investors should buy MEI Pharma Inc (NASDAQ:MEIP) before the American Society of Hematology (ASH) meeting on Decemeber …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts